4//SEC Filing
Herbert Timothy P. 4
Accession 0001104659-24-131302
CIK 0001609550other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:15 PM ET
Size
20.9 KB
Accession
0001104659-24-131302
Insider Transaction Report
Form 4
Herbert Timothy P.
DirectorCEO and President
Transactions
- Other
Stock Option (Right to Buy)
2024-12-20−27,254→ 51,913 total(indirect: By LLC)Exercise: $42.15Exp: 2028-12-18→ Common Stock (27,254 underlying) - Other
Stock Option (Right to Buy)
2024-12-20−13,703→ 26,100 total(indirect: By LLC)Exercise: $194.82Exp: 2030-12-14→ Common Stock (13,703 underlying) - Other
Stock Option (Right to Buy)
2024-12-20−2,915→ 5,553 total(indirect: By LLC)Exercise: $227.53Exp: 2030-12-14→ Common Stock (2,915 underlying) - Other
Stock Option (Right to Buy)
2024-12-20−28,840→ 54,934 total(indirect: By LLC)Exercise: $71.00Exp: 2029-12-16→ Common Stock (28,840 underlying) - Other
Common Stock
2024-12-20−61,770→ 117,658 total(indirect: By LLC)
Holdings
- 17,100
Stock Option (Right to Buy)
Exercise: $194.82Exp: 2030-12-14→ Common Stock (17,100 underlying) - 9,690
Common Stock
- 63,658(indirect: By Trust)
Common Stock
- 9,128
Stock Option (Right to Buy)
Exercise: $71.00Exp: 2029-12-16→ Common Stock (9,128 underlying) - 12,220
Stock Option (Right to Buy)
Exercise: $227.53Exp: 2030-12-14→ Common Stock (12,220 underlying)
Footnotes (5)
- [F1]Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions.
- [F2]Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports.
- [F3]Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
- [F4]The option is fully vested and exercisable.
- [F5]The original grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Documents
Issuer
Inspire Medical Systems, Inc.
CIK 0001609550
Entity typeother
Related Parties
1- filerCIK 0001737136
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:15 PM ET
- Size
- 20.9 KB